7GK-14235-69462
3 vaccinations
4 coded responses
37 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 452 / OH
- Registered
- 2021-03-19
- Relationship
- Self
- Race
- Other
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-18
Dose 1 — Pfizer-BioNTech
-
2021-03-19
Registered in v-safe
-
2021-03-19
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-20
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-25
-
2021-04-01
Survey response — day 14, dose 1MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Be unable to do your normal daily activitiesFree text: I have developed enlarged and painful lymph nodes in the axillary tail of my breast and some in the supraclavicular area.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-08
Dose 2 — Pfizer-BioNTech
- 2021-04-08
- 2021-04-09
- 2021-04-10
- 2021-04-11
- 2021-04-12
- 2021-04-13
- 2021-04-14
- 2021-04-15
- 2021-04-24
- 2021-05-01
-
2021-05-06
Survey response — day 28, dose 2MedDRA: Blister, Dysphonia, Eye pruritus, Headache, Hypersensitivity, Oropharyngeal pain, Pre-existing disease, Rhinorrhoea, Self-medication, Sneezing, Urticaria — Feeling: FairFree text: Unusually hypersensitive to outdoor allergens and bug bites resulting in very large welts, blisters, itchy eyes, sore throat, hoarseness, sneezing, headache, runny nose despite taking usual claritin and were much better with advil and benedryl.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-13
- 2021-05-20
- 2021-07-08
-
2021-10-07
Survey response — 6 months, dose 2MedDRA: Vertigo — Feeling: Good · Be unable to do your normal daily activitiesFree text: I experienced vertigo for about 3 days. It resolved without any evaluation or treatment.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-12
Dose 3 — Pfizer-BioNTech
- 2021-10-12
-
2021-10-13
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Joint pains, Muscle or body achesAdult check-in
- 2021-10-14
- 2021-10-15
- 2021-10-16
-
2021-10-17
Health check-in — days 1–6 daily, dose 3Feeling: Good · Headache · Be unable to do your normal daily activitiesAdult check-in
- 2021-10-18
- 2021-10-19
- 2021-10-26
- 2021-11-02
- 2021-11-09
- 2021-11-17
- 2021-11-23
- 2022-01-11
-
2022-04-14
Survey response — 6 months, dose 3MedDRA: COVID-19, Conjunctivitis — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Covid with conjunctivitis that last 4-5 weeks.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-14
Report sent to call center — 6 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-04-20
-
2022-04-20
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-18 | Pfizer-BioNTech | |
| 2 | 2021-04-08 | Pfizer-BioNTech | |
| 3 | 2021-10-12 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 6 — day 14, dose 1
Symptoms: I have developed enlarged and painful lymph nodes in the axillary tail of my breast and some in the supraclavicular area.
Release 8 — day 28, dose 2
Symptoms: Unusually hypersensitive to outdoor allergens and bug bites resulting in very large welts, blisters, itchy eyes, sore throat, hoarseness, sneezing, headache, runny nose despite taking usual claritin and were much better with advil and benedryl.
Release 10 — 6 months, dose 2
Symptoms: I experienced vertigo for about 3 days. It resolved without any evaluation or treatment.
Release 11 — 6 months, dose 3
Symptoms: Covid with conjunctivitis that last 4-5 weeks.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Blister | ✓ | ✓ | ✓ |
| SD | Conjunctivitis | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dysphonia | ✓ | ✓ | ✓ |
| SD | Eye pruritus | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Hypersensitivity | ✓ | ✓ | ✓ |
| SD | Lymph node pain | ✓ | ✓ | ✓ |
| SD | Lymphadenopathy | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | Self-medication | ✓ | ✓ | ✓ |
| SD | Sneezing | ✓ | ✓ | ✓ |
| SD | Urticaria | ✓ | ✓ | ✓ |
| SD | Vertigo | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release